LYN and acute myeloid leukemia: In this study, we first demonstrated that significant higher expression levels of total Lyn were observed in AML patients with favorable cytogenetics, higher MPO activity and FAB M2 subtype, which is also known as myeloblastic leukemia with maturation (Figs. 1, 2a–c; Table 1).